A purple and pink letter v on a white background.
October 18, 2018

Comparing Radio Frequency-Based Devices: What’s the Best for Business Growth?

For more than 75 years, radio frequency (RF) technology has been used in medicine, with a focus on achieving improved efficacy and patient comfort in the aesthetics industry developing in the last 15 years. As advances in RF-based treatments spanning from body aesthetics to skin resurfacing, wrinkle reduction, and more continue, these treatments have become increasingly popular among consumers. In particular, demand for non-surgical fat reduction treatments saw the procedure come in third place among the most popular non-surgical treatments in the United States in 2017.

But not all radio frequency aesthetics devices work alike. Discover which RF device features offer improved efficacy and patient comfort for better business growth.

RF Basics

Before getting into too much detail, it’s useful to understand the basics of how radio frequency energy can be manipulated for use in aesthetic treatments. RF energy is frequently delivered to the targeted treatment area via an applicator applied to the surface of the skin. The applicator emits radio frequency energy that penetrates deep within the skin, to the deep dermis and sub-dermal layers, converting to thermal heat in targeted tissue. When collagen is heated, it prompts the treated skin to react by producing more collagen for improved texture and elasticity. When fat cells are heated, radio frequency energy induces apoptosis of selected fat cells for an overall reduction in circumference. Because radio frequency energy is electrical, rather than light-based, melanin remains unaffected and post-inflammatory hyperpigmentation is of little concern.

Devices differ by the number and configuration of electrodes in applicators, alongside the varying electromagnetic fields used to deliver the RF energy. Here, we’ll focus in on electrode variations, which can be classified as monopolar, bipolar, or multi-polar.

Monopolar Radio Frequency Devices

The first and most common aesthetics devices harnessing RF energy for cosmetic treatments feature monopolar applicators. Monopolar devices utilize a dedicated applicator with one electrode and a grounding plate. The applicator is applied to the surface of the treatment area, with the grounding plate also being applied to the body, but at a distance from the applicator.

Delivered in this way, monopolar RF offers penetration of up to 20 mm, affecting the deep dermis layer and subcutaneous fat. However, penetration depth varies according to factors such as tissue impedance and applicator area. Depending on a patient’s pain tolerance, monopolar treatments are generally less tolerable to patients. It should be noted that monopolar RF treatments vary from unipolar devices, which also utilize a single electrode for application but lack a return pad or grounding plate.

Bipolar and Multi-Polar Radio Frequency Devices

Bipolar RF devices feature two electrodes in the same applicator, with energy traveling from one electrode into the skin and back to the second electrode on the same handpiece. Bipolar applicators better control and distribute energy between electrodes and offer the improved ability to target more specific dermal structures for improved efficacy, compared to monopolar and unipolar devices.

Multi-Polar RF applicators feature three or more electrodes that utilize the unipolar or monopolar systems of current delivery. These applicators often utilize a pattern that allows for the manipulation of active and inactive electrode pairings for greater operator control and efficacy. Depth of penetration for Multi-Polar RF devices alters depending on the distance between electrodes; the greater the distance between electrodes on the applicator, the greater the depth of penetration.

According to a collection of studies, bipolar and multi-polar devices are regarded as the more versatile option for improved efficacy and patient comfort, as well as minimal downtime when compared to monopolar devices.

Advanced (MP) 2 Radio Frequency Devices

Advanced medical aesthetic treatment devices featuring proprietary (MP) 2 technology combine the proven efficacy and benefits of Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields (PEMF). This combination offers improved collagen production via the proliferation of dermal fibroblasts and the stimulation of new blood cells for healthy cell renewal.  

In particular, Venus Concept’s (MP) 2 -powered devices utilize a multi-polar applicator with energy output controlled by a complex algorithm for even energy distribution between electrodes, resulting in more homogeneous energy delivery and volumetric heating. Combined with advanced safety features like Real-Time Thermal Feedback and Automatic Temperature Control, these treatments ensure patient safety and comfort alongside improved ease of use for the device operator. Overall, Venus Concept (MP) 2 aesthetics devices offer optimal results for many of the most popular non-invasive aesthetics treatments without risking patient comfort or satisfaction. Treatments include body contouring, cellulite reduction, skin tightening, and wrinkle reduction.

Interested in adding radio frequency-based treatments to your aesthetic clinic’s service offerings? Contact an expert today to discover your options.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.